Ekso Bionics Holdings, Inc.
EKSO
$12.40
$0.403.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -25.72% | 105.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -25.72% | 105.49% | |||
| Cost of Revenue | -12.46% | 35.54% | |||
| Gross Profit | -34.44% | 211.23% | |||
| SG&A Expenses | 58.75% | -13.72% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.56% | -6.68% | |||
| Operating Income | -168.12% | 64.73% | |||
| Income Before Tax | -228.92% | 47.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -228.92% | 47.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -228.92% | 47.55% | |||
| EBIT | -168.12% | 64.73% | |||
| EBITDA | -219.61% | 71.23% | |||
| EPS Basic | -168.39% | 56.29% | |||
| Normalized Basic EPS | -125.33% | 56.29% | |||
| EPS Diluted | -168.39% | 56.29% | |||
| Normalized Diluted EPS | -125.33% | 56.29% | |||
| Average Basic Shares Outstanding | 22.55% | 20.00% | |||
| Average Diluted Shares Outstanding | 22.55% | 20.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||